Old Web
English
Sign In
Acemap
>
authorDetail
>
David Calligaris
David Calligaris
Harvard University
Distribution (pharmacology)
Temozolomide
Immunology
Cancer
In vitro
2
Papers
116
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood–Brain Barrier in Glioblastoma
2015
Clinical Cancer Research
Jenny L. Pokorny
David Calligaris
Shiv K. Gupta
Dennis O. Iyekegbe
Dustin Mueller
Katrina K. Bakken
Brett L. Carlson
Mark A. Schroeder
Debra Evans
Zhenkun Lou
Paul A. Decker
Jeanette E. Eckel Passow
Vincenzo Pucci
Bennett Ma
Stuart D. Shumway
William F. Elmquist
Nathalie Y. R. Agar
Jann N. Sarkaria
Show All
Source
Cite
Save
Citations (64)
Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous System
2015
Molecular Cancer Therapeutics
Karen E. Parrish
Ling Cen
James W. Murray
David Calligaris
Sani H. Kizilbash
Rajendar K. Mittapalli
Brett L. Carlson
Mark A. Schroeder
Julieann Sludden
Alan V. Boddy
Nathalie Y. R. Agar
Nicola J. Curtin
William F. Elmquist
Jann N. Sarkaria
Show All
Source
Cite
Save
Citations (52)
1